| Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review L Gervaso, H Dave, AA Khorana Cardio Oncology 3 (2), 173-190, 2021 | 110 | 2021 |
| Increased incidence of venous thromboembolism with cancer immunotherapy J Roopkumar, S Swaidani, AS Kim, B Thapa, L Gervaso, BP Hobbs, ... Med 2 (4), 423-434. e3, 2021 | 85 | 2021 |
| Venous thromboembolism in breast cancer patients receiving cyclin‐dependent kinase inhibitors L Gervaso, AJ Montero, X Jia, AA Khorana Journal of Thrombosis and Haemostasis 18 (1), 162-168, 2020 | 69 | 2020 |
| Risk of thromboembolism in patients with ALK‐and EGFR‐mutant lung cancer: A cohort study J Roopkumar, SK Poudel, L Gervaso, CA Reddy, V Velcheti, NA Pennell, ... Journal of Thrombosis and Haemostasis 19 (3), 822-829, 2021 | 41 | 2021 |
| Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI). B Thapa, J Roopkumar, AS Kim, L Gervaso, PD Patil, C Calabrese, ... Journal of Clinical Oncology 37 (15_suppl), e14151-e14151, 2019 | 24 | 2019 |
| Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study V Zanuso, V Fregoni, L Gervaso Future Science OA 6 (9), FSO617, 2020 | 18 | 2020 |
| Biomarker evaluation in radically resectable locally advanced gastric cancer treated with neoadjuvant chemotherapy: an evidence reappraisal L Gervaso, S Pellicori, CA Cella, V Bagnardi, F Lordick, N Fazio Therapeutic advances in medical oncology 13, 17588359211029559, 2021 | 13 | 2021 |
| Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) D Ciardiello, C Chiarazzo, V Famiglietti, A Damato, C Pinto, MG Zampino, ... ESMO open 7 (5), 100567, 2022 | 11 | 2022 |
| Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis PT Aliaga, F Spada, G Peveri, V Bagnardi, C Fumagalli, A Laffi, M Rubino, ... Cancer Treatment Reviews 99, 102261, 2021 | 10 | 2021 |
| Validation of the ONKOTEV risk prediction model for venous thromboembolism in outpatients with cancer CA Cella, M Knoedler, M Hall, M Arcopinto, V Bagnardi, L Gervaso, ... JAMA network open 6 (2), e230010-e230010, 2023 | 9 | 2023 |
| Nodal Merkel cell carcinoma with unknown primary site and no distant metastasis: A single-center series N Fazio, P Maisonneuve, F Spada, L Gervaso, CA Cella, M Pozzari, ... Cancers 14 (19), 4777, 2022 | 9 | 2022 |
| The prognostic value of the new combined hemo-eosinophil inflammation index (HEI Index): a multicenter analysis of anal cancer patients treated with concurrent chemo-radiation M Rimini, P Franco, B De Bari, MG Zampino, S Vagge, GL Frassinetti, ... Cancers 13 (4), 671, 2021 | 8 | 2021 |
| Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study N Fazio, L Gervaso, TR Halfdanarson, A La Salvia, J Hofland, J Hernando, ... European Journal of Cancer 154, 246-252, 2021 | 7 | 2021 |
| Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma—Is It Based on Evidence or Clinical Wisdom? L Gervaso, F Lordick, N Fazio JAMA oncology 7 (12), 1759-1760, 2021 | 6 | 2021 |
| Ivosidenib for advanced IDH1-mutant cholangiocarcinoma L Gervaso, S Pellicori, N Fazio The Lancet Oncology 21 (8), e370, 2020 | 6 | 2020 |
| Molecular subtyping to predict risk of venous thromboembolism in patients with advanced lung adenocarcinoma: a cohort study L Gervaso, SK Poudel, J Roopkumar, CA Reddy, NA Pennell, V Velcheti, ... Blood 134, 3651, 2019 | 6 | 2019 |
| Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis G Arrivi, F Spada, S Frassoni, V Bagnardi, A Laffi, M Rubino, L Gervaso, ... Journal of Neuroendocrinology 34 (10), e13189, 2022 | 5 | 2022 |
| Addressing the role of angiogenesis in patients with advanced pancreatic neuroendocrine tumors treated with everolimus: A biological prospective analysis of soluble biomarkers … CA Cella, F Spada, A Berruti, F Bertolini, P Mancuso, M Barberis, E Pisa, ... Cancers 14 (18), 4471, 2022 | 5 | 2022 |
| Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysis MI Meneses-Medina, L Gervaso, CA Cella, S Pellicori, S Gandini, ... Cancer Treatment Reviews 104, 102338, 2022 | 5 | 2022 |
| Non-traumatic splenic rupture in amyloidosis as a rare evolution of multiple myeloma L Perrone, L Gervaso, E Bosco, F Serra, E Quaquarini Clinics and Practice 9 (2), 1146, 2019 | 4 | 2019 |
